TRENDS IN ACUTE MYOCARDIAL-INFARCTION PROGNOSIS AND TREATMENT IN SOUTHWESTERN FRANCE BETWEEN 1985 AND 1990 (THE MONICA PROJECT-TOULOUSE)

被引:50
作者
FERRIERES, J
CAMBOU, JP
RUIDAVETS, JB
POUS, J
机构
[1] TOULOUSE UNIV, SCH MED,SCH PUBL HLTH & COMMUNITY MED,ORSMIP, INSERM 326, TOULOUSE, FRANCE
[2] TOULOUSE UNIV, PURPAN HOSP, SCH MED, DEPT CARDIOL, TOULOUSE, FRANCE
关键词
D O I
10.1016/S0002-9149(99)80762-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since 1984, the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA project) has studied progress in acute coronary artery disease (CAD) in defined geographic areas. This study, based in a french MONICA center in Southwestern France, assessed acute myocardial infarction (AMI) frequency, prognosis, and treatment between 1985 and 1990. The age-standardized AMI attack rate showed a slight decrease in men (218.3 of 100,000 in 1985 and 200.1 of 100,000 in 1990, p<0.05). In men, the AMI age-standardized 28-day case fatality rate decreased from 38% in 1985 to 27% in 1990 (p<0.001), with a dramatic reduction in the age-standardized in-hospital case fatality rate (21% in 1985 and 11% in 1990, p<0.001). Furthermore, the in-hospital 28-day case fatality decreased exclusively in male patients with a history of CAD (33% in 1986 and 19% in 1990, p<0.01). AMI treatment improved between 1986 and 1990 with increased use of antiplatelets (40.7% in 1986, 73.6% in 1989, and 84.8% in 1990, p<0.001), beta-blockers (29.5% in 1986, 45.7% in 1989, and 57.7% in 1990, p<0.001), and thrombolytic therapy (23.6% in 1986, 45.3% in 1989, and 39.5% in 1990, p<0.001). Invasive cardiology technique utilization increased dramatically between 1986 and 1990 with the generalized use of coronary angiography (68.2% in 1986, 89.3% in 1989, and 87.3% in 1990, p<0.001) and percutaneous transluminal coronary angioplasty (17.7% in 1986, 49.6% in 1989, and 55.3% in 1990, p<0.001). French data recorded during the MONICA project showed improvements in the prognosis of patients hospitalized for AMI and in the use of effective therapies. These results suggest that physicians respond quickly to newly published clinical trials.
引用
收藏
页码:1202 / 1205
页数:4
相关论文
共 19 条
  • [1] AHA Medical/Scientific Statement, ACC/AHA guidelines for the early management of patients with acute myocardial infarction, Circulation, 82, pp. 664-707, (1990)
  • [2] Lamas, Pfeffer, Hamim, Wertheimer, Rouleau, Braunwald, Do the results of randomized clinical trials of cardiovascular drugs influence medical practice?, N Engl J Med, 327, pp. 241-247, (1992)
  • [3] Tunstall-Pedoe, Kuulasmaa, Amouyel, Arveiler, Rajakangas, Pajak, Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, events rates and case-fatality rates in 38 populations from 21 countries in four continents, Circulation, 90, pp. 583-612, (1994)
  • [4] Douste-Blazy, Ruidavets, Arveiler, Bingham, Camare, Schaffer, Aby, Richard, Comparison of cardiovascular risk factor levels in two French populations: Haute-Garonne (Toulouse) and Bas-Rhin (Strasbourg), Acta Med Scand, 728, pp. 137-143, (1988)
  • [5] Doll, Comparison between registries age-standardized rates, Cancer Incidence in Five Continents, pp. 453-459, (1976)
  • [6] Cortina, Ambrose, Prieto-Granada, Moris, Simarro, Holt, Fuster, Left ventricular function after myocardial infarction: clinical and angiographic correlations, J Am Coll Cardiol, 5, pp. 619-624, (1985)
  • [7] Matsuda, Ogawa, Moritani, Matsuda, Naito, Matsuzaki, Ikee, Kusukawa, Effects of the presence or absence of preceding angina pectoris on left ventricular function after acute myocardial infarction, Am Heart J, 108, pp. 955-958, (1984)
  • [8] Muller, Topol, Califf, Sigmon, Gorman, George, Kereiakes, Lee, Ellis, Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction, Am Heart J, 119, pp. 224-231, (1990)
  • [9] Barbash, White, Modan, Van de Werf, Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial, J Am Coll Cardiol, 20, pp. 36-41, (1992)
  • [10] Mueller, Cohen, Braunwald, Forman, Feit, Ross, Schweiger, Cabin, Davison, Miller, Solomon, Knatterud, Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II, Circulation, 85, pp. 1254-1264, (1992)